Cenicriviroc for the treatment of COVID-19: first interim results of a randomised, placebo-controlled, investigator-initiated, double-blind phase II trial
塞尼西维罗克治疗 COVID-19:一项随机、安慰剂对照、研究者发起、双盲 II 期试验的首批中期结果
期刊:Journal of Global Antimicrobial Resistance
影响因子:3.2
doi:10.1016/j.jgar.2022.12.004
Kurth, Florian; Helbig, Elisa T; Lippert, Lena J; Thibeault, Charlotte; Barbone, Gianluca; Eckart, Marius A; Kluge, Martin; Puengel, Tobias; Demir, Münevver; Röhle, Robert; Keller, Theresa; Ruwwe-Glösenkamp, Christoph; Witzenrath, Martin; Suttorp, Norbert; von Kalle, Christof; Sander, Leif E; Jochum, Christoph; Tacke, Frank